Orlando Scandrick was “thankful” and “relieved” when his four-game suspension was cut short by a revised drug policy. But after his return game, the tone had changed.
Scandrick arrived at at the club’s Valley Ranch headquarters this morning and rejoined the team as the result of the NFL reaching an agreement with the NFL Players Association on changes to its performance-enhancing drug policy.
The NFL says it has reached an agreement with the players association on changes to its performance-enhancing drug policy, including the addition of human growth hormone testing.
Cowboys sources tell 105.3 The Fan that there is “virtually no chance” defensive back Orlando Scandrick will be available to the team for Sunday’s game at Tennessee.
NFL Players Association reps have voted to approve a proposed new drug policy from the league, NFL.com reports.
Player representatives from the league’s 32 NFL teams will spend the next 24 hours reviewing the details of a proposed new drug policy, according to NFL.com.
The Cowboys aren’t planning on the bonus eligibility of cornerback Orlando Scandrick for Sunday’s opener against the 49ers.
The Cowboys defense took a step towards taking shape on Tuesday morning as projected opening-day starting cornerbacks Brandon Carr and Morris Claiborne were both in pads.
The Dallas defense is still missing starters halfway through the preseason and will lose cornerback Orlando Scandrick for the first four games of the regular season.
Jones elaborated on his announcement from Monday that cornerback Orlando Scandrick has been suspended four games for using a banned substance.
Orland Scandrick’s agent, Ron Slavin, joined Shan & RJ on 105.3 The Fan to explain why his client has been suspended by the NFL.
Cowboys owner Jerry Jones revealed the news on Monday, meaning Scandrick will miss games against San Francisco, Tennessee, St. Louis and New Orleans.